Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Johnson and Johnson lanches Institute on Wheels to address India’s needs in surgical education at Doorstep

      Johnson and Johnson lanches Institute on Wheels to address India’s needs in surgical education at Doorstep

      Ruby Khatun Khatun25 March 2018 10:21 AM IST
      NEW DELHI: Johnson and Johnson Medical India announced the launch of its state-of-the-art Johnson & Johnson Institute on Wheels. This is a unique...
      GSKs two-drug HIV regimen wins European panel approval

      GSK's two-drug HIV regimen wins European panel approval

      Ruby Khatun Khatun25 March 2018 10:15 AM IST
      A panel of European Medicines Agency recommended approval for GlaxoSmithKline’s two-drug regimen to treat HIV, the virus that causes AIDS.The...
      Pfizers quit-smoking Chantix fails study in adolescent smokers

      Pfizer's quit-smoking Chantix fails study in adolescent smokers

      Ruby Khatun Khatun25 March 2018 10:00 AM IST
      Pfizer Inc said its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main...
      SFIO probes Fortis, Religare for alleged frauds

      SFIO probes Fortis, Religare for alleged frauds

      Ruby Khatun Khatun24 March 2018 11:00 AM IST
      New Delhi: The Serious Fraud Investigation Office (SFIO) is probing Religare Enterprises and its group company Fortis Healthcare for alleged frauds,...
      Government allocates 100 billion rupees for Modicare health insurance

      Government allocates 100 billion rupees for Modicare health insurance

      Ruby Khatun Khatun24 March 2018 10:30 AM IST
      New Delhi: The Government has allocated 100 billion rupees ($1.54 billion) for its ambitious health programme aimed at providing insurance cover for...
      Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

      Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

      Ruby Khatun Khatun24 March 2018 10:15 AM IST
      Mumbai: Tata Chemicals Ltd., the country’s leading producer of Soda Ash and Sodium Bicarbonate, announced the launch of MedikarbTM – India’s first...
      GlaxoSmithKline has submitted its final bid to buy Pfizer unit: Report

      GlaxoSmithKline has submitted its final bid to buy Pfizer unit: Report

      Ruby Khatun Khatun24 March 2018 10:00 AM IST
      GlaxoSmithKline Plc has submitted a binding bid to acquire Pfizer Inc.’s consumer health unit, people familiar with the matter said, leaving the U.K....
      AbbVies lung cancer drug data disappoints

      AbbVie's lung cancer drug data disappoints

      Ruby Khatun Khatun24 March 2018 9:30 AM IST
      AbbVie Inc’s experimental lung cancer drug data was not effective enough to seek a faster approval, in a setback to the company’s efforts to build its...
      Pharma Export do not need NOC: CDSCO

      Pharma Export do not need NOC: CDSCO

      Ruby Khatun Khatun23 March 2018 4:50 PM IST
      New Delhi: In order to improve ease of doing business Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare,...
      Suven Life gets patents from Norway, S Korea, Singapore

      Suven Life gets patents from Norway, S Korea, Singapore

      Ruby Khatun Khatun23 March 2018 10:45 AM IST
      New Delhi: Suven Life Sciences said that it has been granted a patent each by Norway, South Korea, and Singapore corresponding to new chemical...
      Mylan launches generic Mutamycin injection in US

      Mylan launches generic Mutamycin injection in US

      Ruby Khatun Khatun23 March 2018 10:30 AM IST
      Global pharmaceutical company Mylan NV announced the U.S. launch of the oncology drug Mitomycin for Injection USP, 5 mg/vial, 20 mg/vial and 40...
      Novartis touts US filing plans for MS drug as patent losses loom

      Novartis touts US filing plans for MS drug as patent losses loom

      Ruby Khatun Khatun23 March 2018 10:15 AM IST
      ZURICH: Novartis plans to file its BAF312 multiple sclerosis drug for U.S. approval within weeks, the Swiss drugmaker said, as it seeks to refresh its...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok